Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 20, Issue 3, 2010, Pages 179-186

  Günther, Thomas ^a   Herpertz Dahlmann, Beate ^a   Konrad, Kerstin ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO; CENTRAL STIMULANT AGENT;

AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; COMORBIDITY; COMPUTERIZED ATTENTION TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSLEXIA; FEMALE; HUMAN; IMPULSIVENESS; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MENTAL TEST; MOOD DISORDER; NEUROMODULATION; NEUROPSYCHOLOGICAL TEST; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SCHOOL CHILD; SELECTIVE ATTENTION; SEX DIFFERENCE; SEX RATIO; SINGLE DRUG DOSE; TASK PERFORMANCE; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DRUG EFFECTS; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 77954927604     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2009.0060     Document Type: Article

References (56)

1. Abikoff HB, Jensen PS, Arnold LL, Hoza B, Hechtman L, Pollack S, Martin D, Alvir J, March JS, Hinshaw S, Vitello B, Newcorn J, Greiner A, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Kraemer H, Pelham WEJ, Severe JB, Swanson JM, Wells K, Wigal T: Observed classroom behavior of children with ADHD: Relationship to gender and comorbidity. J Abnorm Child Psychol 4:349-359, 2002.
2. American Academy of Child and Adolescent Psychiatry. A practice parameter for the use of stimulant medications. J Am Acad Child Adolesc Psychiatry 10:26S-49S, 2002.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
4. Balint S, Czobor P, Komlosi S, Meszaros A, Simon V, Bitter I: Attention deficit hyperactivity disorder (ADHD): Gender-and age-related differences in neurocognition. Psychol Med 39: 1337-1345, 2008.
5. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ: Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: Results from a population-based study. J Devel Behav Pediatrics 1:1-10, 2006.
6. Bedard AC, Jain U, Johnson SH, Tannock R: Effects of methylphe-nidate on working memory components: Influence of measurement. J Child Psychol Psychiatry 9:872-880, 2007.
7. Biederman J, Kwon A, Aleardi M, Chouinard VA, Marino T, Cole H, Mick E, Faraone SV: Absence of gender effects on attention deficit hyperactivity disorder: Findings in nonreferred subjects. Am J Psychiatry 6:1083-1089, 2005.
8. Cabeza R, Nyberg L: Imaging Cognition II: An Empirical Review of 275 PET and fMRI Studies. J Cogn Neurosci 1:1-47, 2000.
9. Cahill L: Why sex matters for neuroscience. Nat Rev Neurosci 6:477484, 2006.
10. Carlson CL, Tamm L, Gaub M: Gender differences in children with ADHD, ODD, and co-occurring ADHD/ODD identified in a school population. J Am Acad Child Adolesc Psychiatry 12:1706-1714, 1997.
11. Charach A, Cao H, Schachar R, To T: Correlates of methylphenidate use in Canadian children: A cross-sectional study. Canad J Psychiatry 1:17-26, 2006.
12. Cuffe SP, Moore CG, McKeown RE: Prevalence and correlates of ADHD symptoms in the national health interview survey. J Atten Disord 2:392-401, 2005.
13. de Sonneville LMJ: ANT 2.1-Amsterdam Neuropsychological Tasks. Amstelveen: Sonar, 2000.
14. Dopfner M, Pluck J, Bolte S, Lenz K, Melchers P, Heim K: Eltern-fragebogen uber das Verhalten von Kindern und Jugendlichen (CBCL 4-18). Gottingen: Hogrefe Testzentrale, 1998.
15. Epstein JN, Goldberg N, Conners CK, March JS: The effects of anxiety on CPT performance in an ADHD clinic sample. J Attention Disord 2:45-52, 1997.
16. Epstein JN, Conners CK, Hervey AS, Tonev ST, Arnold LE, Abikoff HB, Elliott G, Greenhill LL, Hechtman L, Hoagwood K, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Wells K, Vitiello B, Wigal T: Assessing medication effects in the MTA study using neu-ropsychological outcomes. J Child Psychol Psychiatry 5:446-456, 2006.
17. Fimm B, Zimmermann P: Testbatterie zur Aufmerksamkeitsiiberprii-fung (TAP)-Version 1.6. Herzogenrath: Psytest, 2001.
18. Gaub M, Carlson CL: Gender differences in ADHD: A meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 8:10361045, 1997.
19. Gershon J: A meta-analytic review of gender differences in ADHD. J Atten Disord 3:143-154, 2002.
20. Guevara J, Lozano P, Wickizer T, Mell L, Gephart H: Psychotropic medication use in a population of children who have attention-deficit/ hyperactivity disorder. Pediatrics 5:733-739, 2002.
21. Gunther T, Jolles J, Herpertz-Dahlmann B, Konrad K: Age-dependent differences in attentional processes in ADHD and disruptive behavior disorder. Develop Neuropsychol 34:422-434, 2009.
22. Halperin JM, O'Brien JD, Newcorn J, H., Healey JM, Pascualvaca D, M., Wolf LE, Young JG: Validation of hyperactive, aggressive, and mixed hyperactive/aggressive childhood disorders: A research note. J Child Psychol Psychiatry 3:455-459, 1990.
23. Hoagwood K, Kelleher KJ, Feil M, Comer DM: Treatment services for children with ADHD: A national perspective. J Am Acad Child Adolesc Psychiatry 2:198-206, 2000.
24. Jacobsen LK, Slotkin TA, Mencl WE, Frost SJ, Pugh KR: Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropsychopharmacology 12:2453-2464, 2007.
25. Justice AJ, de Wit H: Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 1:67-75, 1999.
26. Justice AJ, de Wit H: Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 3:509-515, 2000.
27. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C: Executive function and attention deficit hyperactivity disorder: Stimulant medication and better executive function performance in children. Psychol Med 29:527-538, 1999.
28. Koch K, Pauly K, Kellermann T, Seiferth NY, Reske M, Backes V, Stocker T, Shah NJ, Amunts K, Kircher T, Schneider F, Habel U: Gender differences in the cognitive control of emotion: An fMRI study. Neuropsychologia 12:2744-2754, 2007.
29. Konrad K, Gunther T, Hanisch C, Herpertz-Dahlmann B: Differential effects of methylphenidate on attentional functions in children with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2:191-198, 2004.
30. Levy F, Hay DA, Bennett KS, McStephen M: Gender differences in ADHD subtype comorbidity. J Am Acad Child Adolesc Psychiatry 4:368-376, 2005.
31. Miller AR, Kohen D, Johnston C: Child characteristics and receipt of stimulant medications: A population-based study. Ambul Pediatrics 3:175-181, 2008.
32. Newcorn JH, Halperin JM, Jensen PS, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Epstein JN, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Kraemer HC, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B: Symptom profiles in children with ADHD: effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry 2:137-146, 2001.
33. Piefke M, Weiss PH, Markowitsch HJ, Fink GR: Gender differences in the functional neuroanatomy of emotional episodic autobiographical memory. Hum Brain Mapping 4:313-324, 2005.
34. Polanczyk, G., Faraone, S. V., Bau, C. H., Victor, M. M., Becker, K., Pelz, R. Pelz R, Buitelaar JK, Franke B, Kooij S, van der Meulen E, Cheon KA, Mick E, Purper-Ouakil D, Gorwood P, Stein MA, Cook EH, Rohde LA. The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents. Am J Med Genet B Neuropsychiatr Genet 147B:1419-1424, 2008.
35. Rapport MD, Denney C: Titrating methylphenidate in children with attention deficit/hyperactivity disorder: Is body mass predictive of clinical response. J Am Acad Child Adolesc Psychiatry 4:523-530, 1997.
36. Rucklidge JJ: Gender differences in ADHD: Implications for psychosocial treatments. Exp Rev Neurotherapeut 4:643-655, 2008.
37. Rucklidge JJ, Tannock R: Psychiatric, psychosocial, and cognitive functioning of female adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 5:530-540, 2001.
38. Rushton JL, Fant KE, Clark SJ: Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder. Pediatrics e23:28, 2004.
39. Scahill L, Schwab-Stone M: Epidemiology of ADHD in school-age children. Child Adolesc Psychiatric Clin North Am 9:541-555, 2000.
40. Schatz DB, Rostain AL: ADHD with comorbid anxiety: A review of the current literature. J Atten Disord 2:141-149, 2006.
41. Seidman LJ: Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev 26:466-485, 2006.
42. Seidman LJ, Biederman J, Faraone SV: Impact of gender and age on executive functioning: Do girls and boys with and without attention deficit hyperactivity disorder differ neuropsychologically in preteen and teenage years? Develop Neuropsychol 1:79-105, 2005.
43. Sonuga-Barke EJ, Coghill D, Markowitz JS, Swanson JM, Vanden-berghe M, Hatch SJ: Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate. J Am Acad Child Adolesc Psychiatry 6:701-710, 2007.
44. Spikman JM, Kiers HA, Deelman BG, Van Z, Adriaan H: Construct validity of concepts of attention in healthy controls and patients with CHI. Brain Cogn 47:446-460, 2001.
45. Sprague RL, Sleator E K. Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science 198:1274-1276, 1977.
46. Szatmari P, Offord DR, Boyle MH: Ontario Child Health Study: Prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiatry 2:219-230, 1989.
47. Tabachnick BG, Fidell LS. Using Multivariate Statistics (4). New York: Allyn and Bacon, 2000.
48. Tannock R, Schachar R, Logan GD: Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children. J Ab-norm Child Psychol 23:235-266, 1995.
49. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen H, Christoph, Zuddas A: European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):i7-i30, 2004.
50. Tewes U, Schallberger U, Rossmann K: Hamburg Wechsler In-telligenztest fur Kinder III. Gottingen: Hogrefe, 1999.
51. Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, Kubber S, Linder M, Walitza S, Lange KW: Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology (Berl) 3:315-326, 2006.
52. Unnewehr S, Schneider S, Margraf J: Kinder DIPS-Diagnostisches Interview bei psychischen Storungen im Kindes und Jugendalter. Heidelberg: Springer, 1995.
53. Van der Meere J, Marzocchi GM, De Meo T: Response inhibition and attention deficit hyperactivity disorder with and without opposi-tional defiant disorder screened from a community sample. Develop Neuropsychol 1:459-472, 2005.
54. Van Zomeren AH, Brouwer W, J. Theories and Concepts of Attention. In: Van-Zomeren AH, Brouwer W, J. (Hrsgs): Clinical Neu-ropsychology of Attention (2). New York, Oxford: Oxford University Press, 1994, pp 7-38.
55. Willcutt EG, Pennington BF: Comorbidity of reading disability and attention-deficit/hyperactivity disorder: differences by gender and subtype. J Learn Disabil 2:179-191, 2000.
56. Wodka EL, Mostofsky SH, Prahme C, Gidley Larson JC, Loftis C, Denckla MB, Mark Mahone E: Process examination of executive function in ADHD: Sex and subtype effects. Clin Neuropsycholog 5:826-841, 2008.